T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Univest Financial
UVSP
$1.18B
| $715K | ﹤0.01% |
27,219
| – | – |
|
|
CHMI
1977
Cherry Hill Mortgage Investment Corp
CHMI
$107M
| $710K | ﹤0.01% |
44,383
+5,007
| +13% | +$84.9K |
|
1978
Core Laboratories
CLB
$571M
| $710K | ﹤0.01% |
13,580
| – | – |
|
|
TMHC
1979
DELISTED
Taylor Morrison
TMHC
| $705K | ﹤0.01% |
33,631
+250
| +0.7% | +$4.97K |
|
|
ENDP
1980
DELISTED
Endo International plc
ENDP
| $705K | ﹤0.01% |
171,222
+497
| +0.3% | +$3.14K |
|
1981
Dillards
DDS
$9.93B
| $704K | ﹤0.01% |
11,307
+20
| +0.2% | +$1.29K |
|
|
CTB
1982
DELISTED
Cooper Tire & Rubber Co.
CTB
| $701K | ﹤0.01% |
22,225
+440
| +2% | +$13.4K |
|
|
MFA
1983
MFA Financial
MFA
$925M
| $698K | ﹤0.01% |
24,314
+48
| +0.2% | +$1.4K |
|
1984
SITE Centers
SITC
$156M
| $689K | ﹤0.01% |
66,733
+8,681
| +15% | +$91K |
|
|
GWB
1985
DELISTED
Great Western Bancorp, Inc.
GWB
| $688K | ﹤0.01% |
19,266
+138
| +0.7% | +$4.65K |
|
1986
Century Aluminum
CENX
$4.77B
| $686K | ﹤0.01% |
99,333
+159
| +0.2% | +$1.18K |
|
|
JMP
1987
DELISTED
JMP Group LLC
JMP
| $686K | ﹤0.01% |
175,000
-676,400
| -79% | -$2.65M |
|
1988
Brookdale Senior Living
BKD
$3.1B
| $680K | ﹤0.01% |
94,356
+470
| +0.5% | +$3.1K |
|
|
CSII
1989
DELISTED
Cardiovascular Systems, Inc.
CSII
| $680K | ﹤0.01% |
15,849
-4,209
| -21% | -$163K |
|
|
AMWD
1990
DELISTED
American Woodmark
AMWD
| $679K | ﹤0.01% |
8,019
+1,949
| +32% | +$164K |
|
1991
Omega Flex
OFLX
$304M
| $679K | ﹤0.01% |
8,839
| – | – |
|
1992
Provident Financial Services
PFS
$3.24B
| $679K | ﹤0.01% |
28,000
+134
| +0.5% | +$3.39K |
|
1993
B&G Foods
BGS
$291M
| $678K | ﹤0.01% |
32,595
+117
| +0.4% | +$2.7K |
|
1994
Franklin Electric
FELE
$4.75B
| $677K | ﹤0.01% |
14,263
+107
| +0.8% | +$5.06K |
|
1995
Group 1 Automotive
GPI
$3.17B
| $675K | ﹤0.01% |
8,239
-1,060
| -11% | -$79.7K |
|
|
IVC
1996
DELISTED
Invacare Corporation
IVC
| $675K | ﹤0.01% |
130,045
+35,800
| +38% | +$233K |
|
|
DHC
1997
Diversified Healthcare Trust
DHC
$2.02B
| $673K | ﹤0.01% |
81,392
-1,767
| -2% | -$14.7K |
|
|
INST
1998
DELISTED
Instructure, Inc.
INST
| $673K | ﹤0.01% |
15,827
-589,552
| -97% | -$25.5M |
|
|
ONIT
1999
Onity Group
ONIT
$321M
| $668K | ﹤0.01% |
21,519
+50
| +0.2% | +$1.33K |
|
2000
Mueller Industries
MLI
$15.1B
| $666K | ﹤0.01% |
90,976
+472
| +0.5% | +$3.45K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.